Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives

The kynurenine aminotransferase (KAT) enzymes are pyridoxal 5′-phosphate-dependent homodimers that catalyse the irreversible transamination of kynurenine into kynurenic acid (KYNA) in the tryptophan metabolic pathway. Kynurenic acid is implicated in cognitive diseases such as schizophrenia, and seve...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2017-12, Vol.7 (1), p.17559-11, Article 17559
Main Authors: Jayawickrama, Gayan S., Nematollahi, Alireza, Sun, Guanchen, Gorrell, Mark D., Church, W. Bret
Format: Article
Language:English
Subjects:
119/118
17β-Estradiol
631/154/309/2419
631/154/309/2420
631/154/309/606
631/92/173
631/92/607/1172
82/103
82/16
82/80
82/81
82/83
Acid production
Acids
Cognitive ability
Estrogens
Estrone
Humanities and Social Sciences
Isoenzymes
Kynurenic acid
Kynurenine-oxoglutarate transaminase
Mental disorders
multidisciplinary
Schizophrenia
Science
Science (multidisciplinary)
Sexual dimorphism
Sulfates
Tryptophan
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-3d30f96132bc520a02a0efbe5232ec2f3a425a8d1b7bec6abbcd7e64920463e3
cites cdi_FETCH-LOGICAL-c474t-3d30f96132bc520a02a0efbe5232ec2f3a425a8d1b7bec6abbcd7e64920463e3
container_end_page 11
container_issue 1
container_start_page 17559
container_title Scientific reports
container_volume 7
creator Jayawickrama, Gayan S.
Nematollahi, Alireza
Sun, Guanchen
Gorrell, Mark D.
Church, W. Bret
description The kynurenine aminotransferase (KAT) enzymes are pyridoxal 5′-phosphate-dependent homodimers that catalyse the irreversible transamination of kynurenine into kynurenic acid (KYNA) in the tryptophan metabolic pathway. Kynurenic acid is implicated in cognitive diseases such as schizophrenia, and several inhibitors have been reported that selectively target KAT-II as it is primarily responsible for kynurenic acid production in the human brain. Not only is schizophrenia a sexually dimorphic condition, but women that have schizophrenia have reduced estrogen levels in their serum. Estrogens are also known to interact in the kynurenine pathway therefore exploring these interactions can yield a better understanding of the condition and improve approaches in ameliorating its effects. Enzyme inhibitory assays and binding studies showed that estradiol disulfate is a strong inhibitor of KAT-I and KAT-II (IC 50 : 291.5 μM and 26.3 μM, respectively), with estradiol, estradiol 3-sulfate and estrone sulfate being much weaker (IC 50  > 2 mM). Therefore it is possible that estrogen levels can dictate the balance of kynurenic acid in the brain. Inhibition assay results and modelling suggests that the 17-sulfate moiety in estradiol disulfate is very important in improving its potency as an inhibitor, increasing the inhibition by approximately 10–100 fold compared to estradiol.
doi_str_mv 10.1038/s41598-017-17979-7
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5730616</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1983426504</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-3d30f96132bc520a02a0efbe5232ec2f3a425a8d1b7bec6abbcd7e64920463e3</originalsourceid><addsrcrecordid>eNp1kc1qGzEUhUVJiYObF8iiCLrJZlL9jkabQglpGwh040V3Qpq5Y8vxSIk0Y3CevnKcBLcQbSS43z06h4PQBSVXlPDmaxZU6qYiVFVUaaUr9QGdMSJkxThjJ0fvGTrPeU3KkUwLqk_RjGkmmGTyDP25DSvv_OhjwLHHq2mwAd_vwpQg-ADYDj7EMdmQe0g2A_Y5Pu0GyNjtMOQxxSUEbEOH_ZhxB8lv7ei3kD-hj73dZDh_uedo8eNmcf2ruvv98_b6-13VCiXGinec9LqmnLlWMmIJswR6B7I4h5b13BajtumoUw7a2jrXdgpqoUu8mgOfo28H2YfJDdC1EIrZjXlIfrBpZ6L15t9J8CuzjFsjFSc1rYvA5YtAio9TSWQGn1vYbGyAOGVDtVKqYVLs0S__oes4pVDSFarhgtWSiEKxA9WmmHOC_s0MJWZfnTlUZ0p15rk6o8rS5-MYbyuvRRWAH4BcRmEJ6ejv92X_AsKpptE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1983426504</pqid></control><display><type>article</type><title>Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives</title><source>Publicly Available Content Database</source><source>PubMed</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Jayawickrama, Gayan S. ; Nematollahi, Alireza ; Sun, Guanchen ; Gorrell, Mark D. ; Church, W. Bret</creator><creatorcontrib>Jayawickrama, Gayan S. ; Nematollahi, Alireza ; Sun, Guanchen ; Gorrell, Mark D. ; Church, W. Bret</creatorcontrib><description>The kynurenine aminotransferase (KAT) enzymes are pyridoxal 5′-phosphate-dependent homodimers that catalyse the irreversible transamination of kynurenine into kynurenic acid (KYNA) in the tryptophan metabolic pathway. Kynurenic acid is implicated in cognitive diseases such as schizophrenia, and several inhibitors have been reported that selectively target KAT-II as it is primarily responsible for kynurenic acid production in the human brain. Not only is schizophrenia a sexually dimorphic condition, but women that have schizophrenia have reduced estrogen levels in their serum. Estrogens are also known to interact in the kynurenine pathway therefore exploring these interactions can yield a better understanding of the condition and improve approaches in ameliorating its effects. Enzyme inhibitory assays and binding studies showed that estradiol disulfate is a strong inhibitor of KAT-I and KAT-II (IC 50 : 291.5 μM and 26.3 μM, respectively), with estradiol, estradiol 3-sulfate and estrone sulfate being much weaker (IC 50  &gt; 2 mM). Therefore it is possible that estrogen levels can dictate the balance of kynurenic acid in the brain. Inhibition assay results and modelling suggests that the 17-sulfate moiety in estradiol disulfate is very important in improving its potency as an inhibitor, increasing the inhibition by approximately 10–100 fold compared to estradiol.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-017-17979-7</identifier><identifier>PMID: 29242525</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>119/118 ; 17β-Estradiol ; 631/154/309/2419 ; 631/154/309/2420 ; 631/154/309/606 ; 631/92/173 ; 631/92/607/1172 ; 82/103 ; 82/16 ; 82/80 ; 82/81 ; 82/83 ; Acid production ; Acids ; Cognitive ability ; Estrogens ; Estrone ; Humanities and Social Sciences ; Isoenzymes ; Kynurenic acid ; Kynurenine-oxoglutarate transaminase ; Mental disorders ; multidisciplinary ; Schizophrenia ; Science ; Science (multidisciplinary) ; Sexual dimorphism ; Sulfates ; Tryptophan</subject><ispartof>Scientific reports, 2017-12, Vol.7 (1), p.17559-11, Article 17559</ispartof><rights>The Author(s) 2017</rights><rights>2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-3d30f96132bc520a02a0efbe5232ec2f3a425a8d1b7bec6abbcd7e64920463e3</citedby><cites>FETCH-LOGICAL-c474t-3d30f96132bc520a02a0efbe5232ec2f3a425a8d1b7bec6abbcd7e64920463e3</cites><orcidid>0000-0002-0528-2604 ; 0000-0002-8033-5518</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1983426504/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1983426504?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29242525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jayawickrama, Gayan S.</creatorcontrib><creatorcontrib>Nematollahi, Alireza</creatorcontrib><creatorcontrib>Sun, Guanchen</creatorcontrib><creatorcontrib>Gorrell, Mark D.</creatorcontrib><creatorcontrib>Church, W. Bret</creatorcontrib><title>Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>The kynurenine aminotransferase (KAT) enzymes are pyridoxal 5′-phosphate-dependent homodimers that catalyse the irreversible transamination of kynurenine into kynurenic acid (KYNA) in the tryptophan metabolic pathway. Kynurenic acid is implicated in cognitive diseases such as schizophrenia, and several inhibitors have been reported that selectively target KAT-II as it is primarily responsible for kynurenic acid production in the human brain. Not only is schizophrenia a sexually dimorphic condition, but women that have schizophrenia have reduced estrogen levels in their serum. Estrogens are also known to interact in the kynurenine pathway therefore exploring these interactions can yield a better understanding of the condition and improve approaches in ameliorating its effects. Enzyme inhibitory assays and binding studies showed that estradiol disulfate is a strong inhibitor of KAT-I and KAT-II (IC 50 : 291.5 μM and 26.3 μM, respectively), with estradiol, estradiol 3-sulfate and estrone sulfate being much weaker (IC 50  &gt; 2 mM). Therefore it is possible that estrogen levels can dictate the balance of kynurenic acid in the brain. Inhibition assay results and modelling suggests that the 17-sulfate moiety in estradiol disulfate is very important in improving its potency as an inhibitor, increasing the inhibition by approximately 10–100 fold compared to estradiol.</description><subject>119/118</subject><subject>17β-Estradiol</subject><subject>631/154/309/2419</subject><subject>631/154/309/2420</subject><subject>631/154/309/606</subject><subject>631/92/173</subject><subject>631/92/607/1172</subject><subject>82/103</subject><subject>82/16</subject><subject>82/80</subject><subject>82/81</subject><subject>82/83</subject><subject>Acid production</subject><subject>Acids</subject><subject>Cognitive ability</subject><subject>Estrogens</subject><subject>Estrone</subject><subject>Humanities and Social Sciences</subject><subject>Isoenzymes</subject><subject>Kynurenic acid</subject><subject>Kynurenine-oxoglutarate transaminase</subject><subject>Mental disorders</subject><subject>multidisciplinary</subject><subject>Schizophrenia</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Sexual dimorphism</subject><subject>Sulfates</subject><subject>Tryptophan</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kc1qGzEUhUVJiYObF8iiCLrJZlL9jkabQglpGwh040V3Qpq5Y8vxSIk0Y3CevnKcBLcQbSS43z06h4PQBSVXlPDmaxZU6qYiVFVUaaUr9QGdMSJkxThjJ0fvGTrPeU3KkUwLqk_RjGkmmGTyDP25DSvv_OhjwLHHq2mwAd_vwpQg-ADYDj7EMdmQe0g2A_Y5Pu0GyNjtMOQxxSUEbEOH_ZhxB8lv7ei3kD-hj73dZDh_uedo8eNmcf2ruvv98_b6-13VCiXGinec9LqmnLlWMmIJswR6B7I4h5b13BajtumoUw7a2jrXdgpqoUu8mgOfo28H2YfJDdC1EIrZjXlIfrBpZ6L15t9J8CuzjFsjFSc1rYvA5YtAio9TSWQGn1vYbGyAOGVDtVKqYVLs0S__oes4pVDSFarhgtWSiEKxA9WmmHOC_s0MJWZfnTlUZ0p15rk6o8rS5-MYbyuvRRWAH4BcRmEJ6ejv92X_AsKpptE</recordid><startdate>20171214</startdate><enddate>20171214</enddate><creator>Jayawickrama, Gayan S.</creator><creator>Nematollahi, Alireza</creator><creator>Sun, Guanchen</creator><creator>Gorrell, Mark D.</creator><creator>Church, W. Bret</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0528-2604</orcidid><orcidid>https://orcid.org/0000-0002-8033-5518</orcidid></search><sort><creationdate>20171214</creationdate><title>Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives</title><author>Jayawickrama, Gayan S. ; Nematollahi, Alireza ; Sun, Guanchen ; Gorrell, Mark D. ; Church, W. Bret</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-3d30f96132bc520a02a0efbe5232ec2f3a425a8d1b7bec6abbcd7e64920463e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>119/118</topic><topic>17β-Estradiol</topic><topic>631/154/309/2419</topic><topic>631/154/309/2420</topic><topic>631/154/309/606</topic><topic>631/92/173</topic><topic>631/92/607/1172</topic><topic>82/103</topic><topic>82/16</topic><topic>82/80</topic><topic>82/81</topic><topic>82/83</topic><topic>Acid production</topic><topic>Acids</topic><topic>Cognitive ability</topic><topic>Estrogens</topic><topic>Estrone</topic><topic>Humanities and Social Sciences</topic><topic>Isoenzymes</topic><topic>Kynurenic acid</topic><topic>Kynurenine-oxoglutarate transaminase</topic><topic>Mental disorders</topic><topic>multidisciplinary</topic><topic>Schizophrenia</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Sexual dimorphism</topic><topic>Sulfates</topic><topic>Tryptophan</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jayawickrama, Gayan S.</creatorcontrib><creatorcontrib>Nematollahi, Alireza</creatorcontrib><creatorcontrib>Sun, Guanchen</creatorcontrib><creatorcontrib>Gorrell, Mark D.</creatorcontrib><creatorcontrib>Church, W. Bret</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jayawickrama, Gayan S.</au><au>Nematollahi, Alireza</au><au>Sun, Guanchen</au><au>Gorrell, Mark D.</au><au>Church, W. Bret</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2017-12-14</date><risdate>2017</risdate><volume>7</volume><issue>1</issue><spage>17559</spage><epage>11</epage><pages>17559-11</pages><artnum>17559</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>The kynurenine aminotransferase (KAT) enzymes are pyridoxal 5′-phosphate-dependent homodimers that catalyse the irreversible transamination of kynurenine into kynurenic acid (KYNA) in the tryptophan metabolic pathway. Kynurenic acid is implicated in cognitive diseases such as schizophrenia, and several inhibitors have been reported that selectively target KAT-II as it is primarily responsible for kynurenic acid production in the human brain. Not only is schizophrenia a sexually dimorphic condition, but women that have schizophrenia have reduced estrogen levels in their serum. Estrogens are also known to interact in the kynurenine pathway therefore exploring these interactions can yield a better understanding of the condition and improve approaches in ameliorating its effects. Enzyme inhibitory assays and binding studies showed that estradiol disulfate is a strong inhibitor of KAT-I and KAT-II (IC 50 : 291.5 μM and 26.3 μM, respectively), with estradiol, estradiol 3-sulfate and estrone sulfate being much weaker (IC 50  &gt; 2 mM). Therefore it is possible that estrogen levels can dictate the balance of kynurenic acid in the brain. Inhibition assay results and modelling suggests that the 17-sulfate moiety in estradiol disulfate is very important in improving its potency as an inhibitor, increasing the inhibition by approximately 10–100 fold compared to estradiol.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>29242525</pmid><doi>10.1038/s41598-017-17979-7</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-0528-2604</orcidid><orcidid>https://orcid.org/0000-0002-8033-5518</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2017-12, Vol.7 (1), p.17559-11, Article 17559
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5730616
source Publicly Available Content Database; PubMed; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 119/118
17β-Estradiol
631/154/309/2419
631/154/309/2420
631/154/309/606
631/92/173
631/92/607/1172
82/103
82/16
82/80
82/81
82/83
Acid production
Acids
Cognitive ability
Estrogens
Estrone
Humanities and Social Sciences
Isoenzymes
Kynurenic acid
Kynurenine-oxoglutarate transaminase
Mental disorders
multidisciplinary
Schizophrenia
Science
Science (multidisciplinary)
Sexual dimorphism
Sulfates
Tryptophan
title Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T20%3A22%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20human%20kynurenine%20aminotransferase%20isozymes%20by%20estrogen%20and%20its%20derivatives&rft.jtitle=Scientific%20reports&rft.au=Jayawickrama,%20Gayan%20S.&rft.date=2017-12-14&rft.volume=7&rft.issue=1&rft.spage=17559&rft.epage=11&rft.pages=17559-11&rft.artnum=17559&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-017-17979-7&rft_dat=%3Cproquest_pubme%3E1983426504%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-3d30f96132bc520a02a0efbe5232ec2f3a425a8d1b7bec6abbcd7e64920463e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1983426504&rft_id=info:pmid/29242525&rfr_iscdi=true